Sutton Wealth Advisors Inc. - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 157 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.27 and the average weighting 0.2%.

Quarter-by-quarter ownership
Sutton Wealth Advisors Inc. ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$23,679
-10.1%
509
+0.2%
0.01%
-18.2%
Q3 2022$26,350
+10.4%
508
+0.6%
0.01%
+22.2%
Q2 2022$23,871
-34.4%
505
-1.2%
0.01%
-30.8%
Q1 2022$36,373
-4.6%
511
+0.2%
0.01%0.0%
Q4 2021$38,138
+32.9%
510
+1.0%
0.01%
+18.2%
Q3 2021$28,689
+32.5%
505
+2.6%
0.01%
+37.5%
Q2 2021$21,653
-10.8%
4920.0%0.01%
-20.0%
Q1 2021$24,265
+17.1%
4920.0%0.01%
+11.1%
Q4 2020$20,713
-8.0%
4920.0%0.01%
-18.2%
Q3 2020$22,524
-8.8%
4920.0%0.01%
-15.4%
Q2 2020$24,703
-2.4%
4920.0%0.01%
-18.8%
Q1 2020$25,304
-16.8%
4920.0%0.02%0.0%
Q4 2019$30,396
+2.8%
4920.0%0.02%
-5.9%
Q3 2019$29,559
-28.8%
4920.0%0.02%
-29.2%
Q2 2019$41,515
-11.7%
4920.0%0.02%
-11.1%
Q1 2019$46,996
+34.9%
4920.0%0.03%
+22.7%
Q4 2018$34,848
-17.1%
4920.0%0.02%
-21.4%
Q3 2018$42,046
-26.3%
4920.0%0.03%
-30.0%
Q2 2018$57,023
+43.2%
4920.0%0.04%
+37.9%
Q1 2018$39,808
+37.9%
4920.0%0.03%
+38.1%
Q4 2017$28,871
+25.4%
4920.0%0.02%
+16.7%
Q3 2017$23,026
+30.1%
4920.0%0.02%
+28.6%
Q2 2017$17,702
+16.8%
4920.0%0.01%
+7.7%
Q1 2017$15,154
-8.1%
4920.0%0.01%
-13.3%
Q4 2016$16,482
+25.9%
4920.0%0.02%
+25.0%
Q3 2016$13,092
+20.7%
4920.0%0.01%
+20.0%
Q2 2016$10,8494920.01%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 862,848$42,556,00014.73%
Fairmount Funds Management LLC 171,147$8,441,0003.56%
ARMISTICE CAPITAL, LLC 1,648,000$81,279,0001.87%
FARALLON CAPITAL MANAGEMENT LLC 1,995,000$98,393,0000.49%
Jackson Creek Investment Advisors LLC 21,409$1,056,0000.37%
Hennion & Walsh Asset Management, Inc. 113,940$5,620,0000.34%
Virtus ETF Advisers LLC 14,721$726,0000.31%
Granahan Investment Management 193,416$9,539,0000.20%
Yorktown Management & Research Co Inc 4,500$222,0000.18%
JACOBS LEVY EQUITY MANAGEMENT, INC 242,257$11,948,0000.09%
View complete list of ENANTA PHARMACEUTICALS INC shareholders